Fabrizio Tagliavini
#151,091
Most Influential Person Now
Researcher
Fabrizio Tagliavini's AcademicInfluence.com Rankings
Fabrizio Tagliavinicomputer-science Degrees
Computer Science
#7955
World Rank
#8371
Historical Rank
Computational Linguistics
#1691
World Rank
#1709
Historical Rank
Machine Learning
#3123
World Rank
#3162
Historical Rank
Artificial Intelligence
#3422
World Rank
#3472
Historical Rank
Download Badge
Computer Science
Fabrizio Tagliavini's Degrees
- PhD Computer Science University of Milan
- Masters Computer Engineering University of Bologna
- Bachelors Computer Engineering University of Bologna
Similar Degrees You Can Earn
Why Is Fabrizio Tagliavini Influential?
(Suggest an Edit or Addition)Fabrizio Tagliavini's Published Works
Number of citations in a given year to any of this author's works
Total number of citations to an author for the works they published in a given year. This highlights publication of the most important work(s) by the author
Published Works
- Neurotoxicity of a prion protein fragment (1993) (930)
- Identification of a second bovine amyloidotic spongiform encephalopathy: molecular similarities with sporadic Creutzfeldt-Jakob disease. (2004) (472)
- Presymptomatic cognitive and neuroanatomical changes in genetic frontotemporal dementia in the Genetic Frontotemporal dementia Initiative (GENFI) study: a cross-sectional analysis (2015) (420)
- Frontotemporal dementia and corticobasal degeneration in a family with a P301S mutation in tau. (1999) (395)
- Staging of Neurofibrillary Pathology in Alzheimer's Disease: A Study of the BrainNet Europe Consortium (2008) (371)
- A Recessive Mutation in the APP Gene with Dominant-Negative Effect on Amyloidogenesis (2009) (365)
- Apoptosis mediated neurotoxicity induced by chronic application of beta amyloid fragment 25-35. (1993) (365)
- Aging-related tau astrogliopathy (ARTAG): harmonized evaluation strategy (2015) (340)
- Sporadic human prion diseases: molecular insights and diagnosis (2012) (288)
- Reversion of prion protein conformational changes by synthetic b-sheet breaker peptides (2000) (268)
- Vascular variant of prion protein cerebral amyloidosis with tau-positive neurofibrillary tangles: the phenotype of the stop codon 145 mutation in PRNP. (1996) (267)
- Preamyloid deposits in the cerebral cortex of patients with Alzheimer's disease and nondemented individuals (1988) (266)
- Frontotemporal dementia and its subtypes: a genome-wide association study (2014) (262)
- Down patients: Extracellular preamyloid deposits precede neuritic degeneration and senile plaques (1989) (239)
- Synthetic peptides homologous to prion protein residues 106-147 form amyloid-like fibrils in vitro. (1993) (233)
- Substitutions at codon 22 of Alzheimer's abeta peptide induce diverse conformational changes and apoptotic effects in human cerebral endothelial cells. (2000) (215)
- Anti‐amyloidogenic activity of tetracyclines: studies in vitro (2001) (215)
- Uncovering the heterogeneity and temporal complexity of neurodegenerative diseases with Subtype and Stage Inference (2017) (211)
- Phenotypic Variability of Gerstmann-Straussler-Scheinker Disease is Associated with Prion Protein Heterogeneity (1998) (209)
- Variably protease‐sensitive prionopathy: A new sporadic disease of the prion protein (2010) (207)
- Molecular characteristics of a protease-resistant, amyloidogenic and neurotoxic peptide homologous to residues 106-126 of the prion protein. (1993) (203)
- Evaluation of Quinacrine Treatment for Prion Diseases (2003) (194)
- Tetracyclines affect prion infectivity (2002) (188)
- Sporadic Creutzfeldt-Jakob disease: Co-occurrence of different types of PrPSc in the same brain (1999) (185)
- Conformational polymorphism of the amyloidogenic and neurotoxic peptide homologous to residues 106-126 of the prion protein. (1994) (185)
- Prion Protein Amyloidosis (1996) (182)
- Amyloid protein of Gerstmann‐Sträussler‐Scheinker disease (Indiana kindred) is an 11 kd fragment of prion protein with an N‐terminal glycine at codon 58. (1991) (182)
- Consensus classification of human prion disease histotypes allows reliable identification of molecular subtypes: an inter-rater study among surveillance centres in Europe and USA (2012) (181)
- Fatal familial insomnia (1992) (177)
- Endogenous proteolytic cleavage of normal and disease-associated isoforms of the human prion protein in neural and non-neural tissues. (1998) (176)
- Effectiveness of anthracycline against experimental prion disease in Syrian hamsters. (1997) (172)
- Gerstmann‐Sträussler‐Scheinker disease II. Neurofibrillary tangles and plaques with PrP‐amyloid coexist in an affected family (1989) (170)
- Anti–amyloid β autoantibodies in cerebral amyloid angiopathy–related inflammation: Implications for amyloid‐modifying therapies (2013) (164)
- Codeposition of Cystatin C with Amyloid‐β Protein in the Brain of Alzheimer Disease Patients (2001) (164)
- Tetracycline affects abnormal properties of synthetic PrP peptides and PrP(Sc) in vitro. (2000) (159)
- Conversion of the BASE Prion Strain into the BSE Strain: The Origin of BSE? (2007) (159)
- Prions in the urine of patients with variant Creutzfeldt-Jakob disease. (2014) (156)
- Pre‐symptomatic detection of prions by cyclic amplification of protein misfolding (2005) (150)
- Detection of misfolded Aβ oligomers for sensitive biochemical diagnosis of Alzheimer's disease. (2014) (144)
- Doxycycline in Creutzfeldt-Jakob disease: a phase 2, randomised, double-blind, placebo-controlled trial (2014) (141)
- Patterns of gray matter atrophy in genetic frontotemporal dementia: results from the GENFI study (2018) (139)
- Amyloid fibrils in Gerstmann-Sträussler-Scheinker disease (Indiana and Swedish Kindreds) express only PrP peptides encoded by the mutant allele (1994) (137)
- Basal nucleus of meynert A neuropathological study in Alzheimer's disease, simple senile dementia, Pick's disease and Huntington's chorea (1983) (136)
- Microglial cells respond to amyloidogenic PrP peptide by the production of inflammatory cytokines. (1999) (131)
- A 7-kDa Prion Protein (PrP) Fragment, an Integral Component of the PrP Region Required for Infectivity, Is the Major Amyloid Protein in Gerstmann-Sträussler-Scheinker Disease A117V* (2001) (121)
- Coexistence of Alzheimer's amyloid precursor protein and amyloid protein in cerebral vessel walls. (1990) (120)
- Detection of prions in blood from patients with variant Creutzfeldt-Jakob disease (2016) (118)
- Amyloid β plaque-associated proteins C1q and SAP enhance the Aβ1–42 peptide-induced cytokine secretion by adult human microglia in vitro (2003) (111)
- Intraspecies Transmission of BASE Induces Clinical Dullness and Amyotrophic Changes (2008) (109)
- A Neurotoxic Prion Protein Fragment Induces Rat Astroglial Proliferation and Hypertrophy (1994) (104)
- Cerebrospinal fluid real‐time quaking‐induced conversion is a robust and reliable test for sporadic creutzfeldt–jakob disease: An international study (2016) (102)
- Molecular determinants of the physicochemical properties of a critical prion protein region comprising residues 106-126. (1999) (102)
- Deep Learning Representation from Electroencephalography of Early-Stage Creutzfeldt-Jakob Disease and Features for Differentiation from Rapidly Progressive Dementia (2017) (97)
- Prion proteins with different conformations accumulate in Gerstmann-Sträussler-Scheinker disease caused by A117V and F198S mutations. (2001) (96)
- Serum neurofilament light chain in genetic frontotemporal dementia: a longitudinal, multicentre cohort study (2019) (96)
- Mutant Prion Protein Expression Causes Motor and Memory Deficits and Abnormal Sleep Patterns in a Transgenic Mouse Model (2008) (96)
- α-Synuclein Amyloids Hijack Prion Protein to Gain Cell Entry, Facilitate Cell-to-Cell Spreading and Block Prion Replication (2017) (95)
- The Efficacy of Tetracyclines in Peripheral and Intracerebral Prion Infection (2008) (94)
- NEURONAL COUNTS IN BASAL NUCLEUS OF MEYNERT IN ALZHEIMER DISEASE AND IN SIMPLE SENILE DEMENTIA (1983) (89)
- A soluble form of prion protein in human cerebrospinal fluid: implications for prion-related encephalopathies. (1992) (89)
- A new function of microtubule-associated protein tau: Involvement in chromosome stability (2008) (88)
- Alzheimer patients and Down patients: Cerebral preamyloid deposits differ ultrastructurally and histochemically from the amyloid of senile plaques (1989) (88)
- Cerebral preamyloid deposits and congophilic angiopathy in aged dogs (1990) (88)
- Anti-Aβ autoantibodies in the CSF of a patient with CAA-related inflammation: A case report (2011) (87)
- Hereditary cerebral hemorrhage with amyloidosis associated with the E693K mutation of APP. (2010) (87)
- Optimal Plasma Progranulin Cutoff Value for Predicting Null Progranulin Mutations in Neurodegenerative Diseases: A Multicenter Italian Study (2011) (87)
- Tau protein directly interacts with the amyloid β-protein precursor: Implications for Alzheimer's disease (1995) (86)
- Common variants in Alzheimer’s disease and risk stratification by polygenic risk scores (2021) (85)
- Chronic wasting disease and atypical forms of bovine spongiform encephalopathy and scrapie are not transmissible to mice expressing wild-type levels of human prion protein. (2012) (84)
- Potential genetic modifiers of disease risk and age at onset in patients with frontotemporal lobar degeneration and GRN mutations: a genome-wide association study (2018) (83)
- The basal nucleus of Meynert in patients with progressive supranuclear palsy (1984) (82)
- Prion protein fragment 106–126 induces apoptotic cell death and impairment of L‐type voltage‐sensitive calcium channel activity in the GH3 cell line (1998) (82)
- Apoptotic Cell Death and Impairment of L-Type Voltage-Sensitive Calcium Channel Activity in Rat Cerebellar Granule Cells Treated with the Prion Protein Fragment 106–126 (2000) (81)
- Identification of evolutionarily conserved gene networks mediating neurodegenerative dementia. (2018) (81)
- Oxidative Damage to Nucleic Acids in Human Prion Disease (2002) (81)
- PrP27-30 is a normal soluble prion protein fragment released by human platelets. (1996) (80)
- Efficient RT-QuIC seeding activity for α-synuclein in olfactory mucosa samples of patients with Parkinson’s disease and multiple system atrophy (2019) (79)
- P3-357 Structural properties of gerstmann-Sträussler-Scheinker disease amyloid protein (2003) (77)
- A new face for old antibiotics: tetracyclines in treatment of amyloidoses. (2013) (76)
- The basal nucleus of Meynert in idiopathic Parkinson's disease (1984) (76)
- Amyloid beta plaque-associated proteins C1q and SAP enhance the Abeta1-42 peptide-induced cytokine secretion by adult human microglia in vitro. (2003) (75)
- Plasma glial fibrillary acidic protein is raised in progranulin-associated frontotemporal dementia (2020) (75)
- Defined α-synuclein prion-like molecular assemblies spreading in cell culture (2014) (73)
- A novel PSEN2 mutation associated with a peculiar phenotype (2008) (68)
- p38 MAP Kinase Mediates the Cell Death Induced by PrP106–126 in the SH-SY5Y Neuroblastoma Cells (2002) (68)
- Apoptosis-mediated neurotoxicity induced by β-amyloid and PRP fragments (1996) (67)
- Iatrogenic Creutzfeldt-Jakob disease with Amyloid-β pathology: an international study (2018) (67)
- The Stimulation of Inducible Nitric-oxide Synthase by the Prion Protein Fragment 106–126 in Human Microglia Is Tumor Necrosis Factor-α-dependent and Involves p38 Mitogen-activated Protein Kinase* (2001) (67)
- Diagnostic differentiation of mild cognitive impairment due to Alzheimer's disease using a hippocampus‐dependent test of spatial memory (2015) (65)
- Neurofibrillary tangles of the Indiana kindred of Gerstmann-Stra¨ussler-Scheinker disease share antigenic determinants with those of Alzheimer disease (1990) (65)
- New insights on the genetic etiology of Alzheimer’s and related dementia (2020) (64)
- MM2‐Thalamic Creutzfeldt–Jakob Disease: Neuropathological, Biochemical and Transmission Studies Identify a Distinctive Prion Strain (2012) (63)
- Prion deposition in olfactory biopsy of sporadic Creutzfeldt–Jakob disease (2004) (62)
- A family with Alzheimer disease and strokes associated with A713T mutation of the APP gene (2004) (61)
- Redox metals and oxidative abnormalities in human prion diseases (2005) (61)
- Alzheimer's disease amyloid precursor protein is present in senile plaques and cerebrospinal fluid: immunohistochemical and biochemical characterization. (1989) (61)
- Hereditary prion protein amyloidoses. (2003) (61)
- Transgenic Fatal Familial Insomnia Mice Indicate Prion Infectivity-Independent Mechanisms of Pathogenesis and Phenotypic Expression of Disease (2015) (61)
- A Neurotoxic and Gliotrophic Fragment of the Prion Protein Increases Plasma Membrane Microviscosity (1997) (59)
- Inter‐Laboratory Assessment of PrPSc Typing in Creutzfeldt–Jakob Disease: A Western Blot Study within the NeuroPrion Consortium (2009) (59)
- White matter hyperintensities are seen only in GRN mutation carriers in the GENFI cohort (2017) (58)
- Conformational plasticity of the Gerstmann-Sträussler-Scheinker disease peptide as indicated by its multiple aggregation pathways. (2008) (57)
- Alzheimer patients and Down patients: Abnormal presynaptic terminals are related to cerebral preamyloid deposits (1990) (56)
- Neuropathology of the recessive A673V APP mutation: Alzheimer disease with distinctive features (2010) (56)
- Alzheimer patients: preamyloid deposits are more widely distributed than senile plaques throughout the central nervous system (1989) (56)
- Tauopathy in human and experimental variant Creutzfeldt-Jakob disease (2008) (56)
- Molecular subtypes of Alzheimer’s disease (2018) (55)
- An APOE haplotype associated with decreased ε4 expression increases the risk of late onset Alzheimer's disease. (2011) (55)
- Channels formed with a mutant prion protein PrP(82-146) homologous to a 7-kDa fragment in diseased brain of GSS patients. (2003) (54)
- Proteinase-K-Resistant Prion Protein Isoforms in Gerstmann-Straussler-Scheinker Disease (Indiana Kindred) (1996) (54)
- Tetracycline prevents Aβ oligomer toxicity through an atypical supramolecular interaction. (2011) (54)
- Neuropathology of Gerstmann‐Sträussler‐Scheinker disease (2000) (54)
- Creutzfeldt‐Jakob Disease: Carnoy's Fixative Improves the Immunohistochemistry of the Proteinase K‐ Resistant Prion Protein (2000) (53)
- Intracellular mechanisms mediating the neuronal death and astrogliosis induced by the prion protein fragment 106–126 (2000) (53)
- Preventive study in subjects at risk of fatal familial insomnia: Innovative approach to rare diseases (2015) (52)
- Neurotoxicity of the Putative Transmembrane Domain of the Prion Protein (2000) (51)
- Specific Recognition of Biologically Active Amyloid-β Oligomers by a New Surface Plasmon Resonance-based Immunoassay and an in Vivo Assay in Caenorhabditis elegans* (2012) (51)
- Mutations in MAPT gene cause chromosome instability and introduce copy number variations widely in the genome. (2013) (50)
- Activation effects of a prion protein fragment [PrP-(106-126)] on human leucocytes. (1996) (50)
- Mutant Presenilin 1 Increases the Expression and Activity of BACE1* (2009) (50)
- Ectopic White Matter Neurons, a Developmental Abnormality That May Be Caused by the PSEN1 S169L Mutation in a Case of Familial AD with Myoclonus and Seizures (2001) (50)
- Tetracyclines and prion infectivity. (2009) (50)
- A68 is a component of paired helical filaments of Gerstmann-Sträussler-Scheinker disease, Indiana kindred (1993) (49)
- Creutzfeldt–Jakob disease with a novel four extra-repeat insertional mutation in the PrP gene (2000) (49)
- C9ORF72 hexanucleotide repeat number in frontotemporal lobar degeneration: a genotype-phenotype correlation study. (2013) (48)
- Amyloid in alzheimer's disease and prion-related encephalopathies: Studies with synthetic peptides (1996) (47)
- Prion protein preamyloid and amyloid deposits in Gerstmann-Sträussler-Scheinker disease, Indiana kindred. (1992) (47)
- A genome-wide screening and SNPs-to-genes approach to identify novel genetic risk factors associated with frontotemporal dementia (2015) (46)
- The Peculiar Role of the A2V Mutation in Amyloid-β (Aβ) 1–42 Molecular Assembly* (2014) (46)
- Studies on peptide fragments of prion proteins. (2001) (46)
- Cognitive reserve and TMEM106B genotype modulate brain damage in presymptomatic frontotemporal dementia: a GENFI study (2017) (46)
- The Semantic Variant of Primary Progressive Aphasia: Clinical and Neuroimaging Evidence in Single Subjects (2015) (44)
- Loss of exosomes in progranulin-associated frontotemporal dementia (2016) (44)
- New mutations in MAPT gene causing frontotemporal lobar degeneration: biochemical and structural characterization (2012) (44)
- Parenchymal preamyloid and amyloid deposits in the brains of patients with hereditary cerebral hemorrhage with amyloidosis—Dutch type (1990) (44)
- Recurrent generalized seizures, visual loss, and palinopsia as phenotypic features of neuronal ceroid lipofuscinosis due to progranulin gene mutation (2014) (44)
- Fatal familial insomnia (1998) (43)
- The G389R mutation in the MAPT gene presenting as sporadic corticobasal syndrome (2008) (43)
- Neuropathological and Clinical Phenotype of an Italian Alzheimer Family with M239V Mutation of Presenilin 2 Gene (2004) (43)
- Comparison of arterial spin labeling registration strategies in the multi‐center GENetic frontotemporal dementia initiative (GENFI) (2018) (43)
- Guidelines for the diagnosis of dementia and Alzheimer's disease (2000) (43)
- A novel Italian presenilin 2 gene mutation with prevalent behavioral phenotype. (2009) (42)
- Multicentre, cross-cultural, population-based, case–control study of physical activity as risk factor for amyotrophic lateral sclerosis (2018) (41)
- Periodic electroencephalogram complexes in a patient with variant Creutzfeldt–Jakob disease (2006) (40)
- Detection of prion seeding activity in the olfactory mucosa of patients with Fatal Familial Insomnia (2017) (40)
- Pathogenic Huntingtin Repeat Expansions in Patients with Frontotemporal Dementia and Amyotrophic Lateral Sclerosis (2020) (40)
- Differential overexpression of SERPINA3 in human prion diseases (2017) (39)
- Progranulin plasma levels predict the presence of GRN mutations in asymptomatic subjects and do not correlate with brain atrophy: results from the GENFI study (2018) (39)
- Presymptomatic white matter integrity loss in familial frontotemporal dementia in the GENFI cohort: A cross‐sectional diffusion tensor imaging study (2018) (39)
- Synthetic Miniprion PrP106* (2002) (39)
- Therapy in prion diseases. (2013) (38)
- Neuronal pentraxin 2: a synapse-derived CSF biomarker in genetic frontotemporal dementia (2020) (38)
- Progressive supranuclear palsy and Parkinson's disease in a family with a new mutation in the tau gene (2004) (38)
- Different mutations at V363 MAPT codon are associated with atypical clinical phenotypes and show unusual structural and functional features (2014) (38)
- Prodromal Alzheimer's disease presenting as cerebral amyloid angiopathy-related inflammation with spontaneous amyloid-related imaging abnormalities and high cerebrospinal fluid anti-Aβ autoantibodies. (2015) (37)
- Frontotemporal lobar degeneration: old knowledge and new insight into the pathogenetic mechanisms of tau mutations (2015) (37)
- Gerstmann-Sträussler-Scheinker Disease (PRNP P102L): Amyloid Deposits Are Best Recognized by Antibodies Directed to Epitopes in PrP Region 90-165 (1995) (37)
- beta PP and Tau interaction. A possible link between amyloid and neurofibrillary tangles in Alzheimer's disease. (1996) (37)
- Apoptosis-mediated neurotoxicity induced by beta-amyloid and PrP fragments. (1996) (36)
- APE1/Ref-1 in Alzheimer's disease: An immunohistochemical study (2009) (36)
- Precocious loss of physiological sleep in a case of Creutzfeldt Jakob disease: a serial polygraphic study. (1995) (35)
- Guidelines for Mapping Areas at Risk of Landslides in Europe (2007) (35)
- Gerstmann-Sträussler-Scheinker Disease Amyloid Protein Polymerizes According to the “Dock-and-Lock” Model* (2006) (35)
- Normal Pressure Hydrocephalus and Parkinsonism: Preliminary Data on Neurosurgical and Neurological Treatment. (2016) (35)
- Combining drug and music therapy in patients with moderate Alzheimer’s disease: a randomized study (2018) (35)
- Cerebral perfusion changes in presymptomatic genetic frontotemporal dementia: a GENFI study (2019) (35)
- Neurotoxic and Gliotrophic Activity of a Synthetic Peptide Homologous to Gerstmann–Sträussler–Scheinker Disease Amyloid Protein (2007) (34)
- Distinct Neuroanatomical Correlates of Neuropsychiatric Symptoms in the Three Main Forms of Genetic Frontotemporal Dementia in the GENFI Cohort (2018) (34)
- The Central Biobank and Virtual Biobank of BIOMARKAPD: A Resource for Studies on Neurodegenerative Diseases (2015) (34)
- Expression in E. coli and purification of recombinant fragments of wild type and mutant human prion protein (2002) (33)
- Diffuse thalamic degeneration in fatal familial insomnia. A morphometric study (1997) (33)
- Prion protein preamyloid and amyloid deposits in Gerstmann-Sträussler-Scheinker disease, Indiana kindred (1992) (33)
- A case of dementia parkinsonism resembling progressive supranuclear palsy due to mutation in the tau protein gene. (2003) (32)
- Sporadic Creutzfeldt-Jakob Disease: The Extent of Microglia Activation Is Dependent on the Biochemical Type of PrPSc (2005) (32)
- Clusterin (SGP‐2) Induction in Rat Astroglial Cells Exposed to Prion Protein Fragment 106–126 (1996) (31)
- A novel class of potential prion drugs: preliminary in vitro and in vivo data for multilayer coated gold nanoparticles. (2010) (31)
- Distinct patterns of brain atrophy in Genetic Frontotemporal Dementia Initiative (GENFI) cohort revealed by visual rating scales (2018) (31)
- Polymorphism at codon 129 of PRNP affects the phenotypic expression of Creutzfeldt‐Jakob disease linked to E200K mutation (2000) (31)
- Functional network resilience to pathology in presymptomatic genetic frontotemporal dementia (2019) (31)
- Brain functional network integrity sustains cognitive function despite atrophy in presymptomatic genetic frontotemporal dementia (2019) (30)
- Creutzfeldt-Jakob disease with a novel extra-repeat insertional mutation in the PRNP gene (2003) (30)
- Progression of Behavioral Disturbances and Neuropsychiatric Symptoms in Patients With Genetic Frontotemporal Dementia (2021) (30)
- A C6orf10/LOC101929163 locus is associated with age of onset in C9orf72 carriers (2018) (30)
- A C6orf10/LOC101929163 locus is associated with age of onset in C9orf72 carriers (2018) (30)
- Erratum: Prion protein preamyloid and amyloid deposits in Gerstmann- Straussler-Scheinker disease, Indiana kindred (Proc. Natl. Acad. Sci. USA (October 1, 1992) 89:19 (9349-9353)) (1993) (29)
- Determination of solution conformations of PrP106-126, a neurotoxic fragment of prion protein, by 1H NMR and restrained molecular dynamics. (1999) (29)
- Validation of landslide hazard assessment by means of GPS monitoring technique – a case study in the Dolomites (Eastern Alps, Italy) (2007) (29)
- Susceptible genes and disease mechanisms identified in frontotemporal dementia and frontotemporal dementia with Amyotrophic Lateral Sclerosis by DNA-methylation and GWAS (2017) (29)
- Good gene, bad gene: New APP variant may be both (2012) (29)
- APP mutations in the Aβ coding region are associated with abundant cerebral deposition of Aβ38 (2012) (29)
- Pathologic prion protein is specifically recognized in situ by a novel PrP conformational antibody (2006) (29)
- Spontaneous spongiform encephalopathy in a young adult rhesus monkey (1996) (28)
- Expression of A2V-mutated Aβ in Caenorhabditis elegans results in oligomer formation and toxicity (2014) (28)
- Analysis of Conformational Stability of Abnormal Prion Protein Aggregates across the Spectrum of Creutzfeldt-Jakob Disease Prions (2016) (27)
- Differential early subcortical involvement in genetic FTD within the GENFI cohort (2021) (26)
- Brain delivery of AAV9 expressing an anti-PrP monovalent antibody delays prion disease in mice (2012) (26)
- Plasma Neurofilament Light for Prediction of Disease Progression in Familial Frontotemporal Lobar Degeneration (2021) (26)
- Lipofuscin Hypothesis of Alzheimer's Disease (2011) (26)
- Atypical tauopathy with massive involvement of the white matter (2008) (25)
- Mutations in MAPT give rise to aneuploidy in animal models of tauopathy (2013) (25)
- Codeposition of cystatin C with amyloid-ß protein in the brain of Alzheimer's disease patients (2000) (25)
- Atypical presentation of Creutzfeldt–Jakob disease: The first Italian case associated with E196K mutation in the PRNP gene (2008) (25)
- White matter hyperintensities in progranulin-associated frontotemporal dementia: A longitudinal GENFI study (2019) (24)
- Towards an early clinical diagnosis of sporadic CJD VV2 (ataxic type) (2017) (24)
- Spontaneous ARIA-like Events in Cerebral Amyloid Angiopathy–Related Inflammation (2021) (24)
- Constant Transmission Properties of Variant Creutzfeldt-Jakob Disease in 5 Countries (2012) (24)
- Myoclonus in Creutzfeldt‐Jakob disease: Polygraphic and video‐electroencephalography assessment of 109 patients (2010) (24)
- An In Vivo 11C-(R)-PK11195 PET and In Vitro Pathology Study of Microglia Activation in Creutzfeldt-Jakob Disease (2018) (24)
- Atypical frontotemporal dementia as a new clinical phenotype of Gerstmann-Straussler-Scheinker disease with the PrP-P102L mutation. Description of a previously unreported Italian family (2008) (24)
- Atypical tauopathy in a patient with LRRK2‐G2019S mutation and tremor‐dominant Parkinsonism (2012) (24)
- Complexes of amyloid-beta and cystatin C in the human central nervous system. (2009) (24)
- Infectivity in Skeletal Muscle of Cattle with Atypical Bovine Spongiform Encephalopathy (2012) (24)
- Hemoglobin mRNA Changes in the Frontal Cortex of Patients with Neurodegenerative Diseases (2018) (23)
- Activation of human microglia by fibrillar prion protein-related peptides is enhanced by amyloid-associated factors SAP and C1q (2005) (23)
- An antibody raised against a conserved sequence of the prion protein recognizes pathological isoforms in human and animal prion diseases, including Creutzfeldt-Jakob disease and bovine spongiform encephalopathy. (1998) (23)
- Social cognition impairment in genetic frontotemporal dementia within the GENFI cohort (2020) (23)
- Apathy in presymptomatic genetic frontotemporal dementia predicts cognitive decline and is driven by structural brain changes (2020) (22)
- Stereotypic behaviors in degenerative dementias (2012) (22)
- Neuronal loss in the basal nucleus of meynert in progressive supranuclear palsy (2004) (21)
- A call for a global COVID-19 Neuro Research Coalition (2020) (21)
- Neocortical variation of Abeta load in fully expressed, pure Alzheimer's disease. (2010) (21)
- Education modulates brain maintenance in presymptomatic frontotemporal dementia (2019) (21)
- Role of Plasminogen in Propagation of Scrapie (2005) (20)
- Synthetic prions with novel strain-specified properties (2015) (20)
- Early symptoms in symptomatic and preclinical genetic frontotemporal lobar degeneration (2020) (20)
- Therapeutic approaches to prion diseases (2000) (20)
- Tau Mutations Serve as a Novel Risk Factor for Cancer. (2018) (19)
- The anti-fibrillogenic activity of tetracyclines on PrP 106–126: a 3D-QSAR study (2008) (19)
- Alzheimer patients: Preamyloid deposits are immunoreactive with antibodies to extracellular domains of the amyloid precursor protein (1991) (19)
- A novel progranulin mutation causing frontotemporal lobar degeneration with heterogeneous phenotypic expression. (2011) (19)
- Tackling amyloidogenesis in Alzheimer’s disease with A2V variants of Amyloid-β (2016) (19)
- Genetic Counseling and Testing for Alzheimer's Disease and Frontotemporal Lobar Degeneration: An Italian Consensus Protocol. (2016) (19)
- Alzheimer neuropathology without frontotemporal lobar degeneration hallmarks (TAR DNA‐binding protein 43 inclusions) in missense progranulin mutation Cys139Arg (2018) (18)
- The &egr; Isoform of 14-3-3 Protein Is a Component of the Prion Protein Amyloid Deposits of Gerstmann-Sträussler-Scheinker Disease (2007) (18)
- A PP Peptide Carboxyl-Terminal to A Is Neurotoxic (1999) (18)
- Lewy body pathology and typical Parkinson disease in a patient with a heterozygous (R275W) mutation in the Parkin gene (PARK2) (2012) (18)
- Anderson-Fabry's disease: Neuropathological and neurochemical investigation (2004) (18)
- Spontaneous ARIA-like Events in Cerebral Amyloid Angiopathy – Related In fl ammation A Multicenter Prospective Longitudinal Cohort Study (17)
- Preamyloid Deposits, Amyloid Deposits, and Senile Plaques in Alzheimer's Disease, Down Syndrome, and Aging (1991) (17)
- A data-driven disease progression model of fluid biomarkers in genetic frontotemporal dementia (2021) (17)
- Asymmetrical cerebral atrophy in Alzheimer's disease. (1991) (17)
- Creutzfeldt–Jakob disease with E200K PRNP mutation: a case report and revision of the literature (2009) (17)
- A modified Camel and Cactus Test detects presymptomatic semantic impairment in genetic frontotemporal dementia within the GENFI cohort (2020) (17)
- COVID-19 Vaccination in Fragile Patients: Current Evidence and an Harmonized Transdisease Trial (2021) (16)
- Ventricular volume expansion in presymptomatic genetic frontotemporal dementia (2019) (16)
- Clinical trials of prion disease therapeutics. (2019) (16)
- Fabry's disease with familial lymphedema of the lower limbs. Case report and family study. (1979) (15)
- PMCA-replicated PrPD in urine of vCJD patients maintains infectivity and strain characteristics of brain PrPD: Transmission study (2019) (15)
- Low-dose CT for the spatial normalization of PET images: A validation procedure for amyloid-PET semi-quantification (2018) (15)
- Neuro-telehealth for fragile patients in a tertiary referral neurological institute during the COVID-19 pandemic in Milan, Lombardy (2021) (15)
- Pathogenic Aβ A2V versus protective Aβ A2T mutation: Early stage aggregation and membrane interaction. (2017) (15)
- Changes in excitability of CA1 pyramidal neurons in slices prepared from AlCl3-treated rabbits (1990) (15)
- Spatiotemporal analysis for detection of pre-symptomatic shape changes in neurodegenerative diseases: Initial application to the GENFI cohort (2019) (15)
- Comparison of 2-D and 3-D computer models for the M. Salta rock fall, Vajont Valley, northern Italy (2009) (15)
- Analysis of brain atrophy and local gene expression in genetic frontotemporal dementia (2019) (15)
- Relationship between non-fibrillary amyloid precursors and cell processes in the cortical neuropil of Alzheimer patients (1991) (15)
- The Italian INTERCEPTOR Project: From the Early Identification of Patients Eligible for Prescription of Antidementia Drugs to a Nationwide Organizational Model for Early Alzheimer's Disease Diagnosis. (2019) (15)
- Italian consensus recommendations for a biomarker‐based aetiological diagnosis in mild cognitive impairment patients (2020) (15)
- Faster Cortical Thinning and Surface Area Loss in Presymptomatic and Symptomatic C9orf72 Repeat Expansion Adult Carriers (2020) (15)
- Review: PrP 106‐126 – 25 years after (2019) (14)
- Rocky Headwaters in the Dolomites, Italy: Field Observations and Topographic Analysis (2008) (14)
- The cell-permeable Aβ1-6A2VTAT(D) peptide reverts synaptopathy induced by Aβ1-42wt (2016) (14)
- Alzheimer’s disease: the controversial approval of Aducanumab (2021) (14)
- The new β amyloid-derived peptide Aβ1–6A2V-TAT(D) prevents Aβ oligomer formation and protects transgenic C. elegans from Aβ toxicity (2016) (13)
- A novel pathogenic PSEN1 mutation in a family with Alzheimer's disease: phenotypical and neuropathological features. (2011) (13)
- Missense mutations in progranulin gene associated with frontotemporal lobar degeneration: study of pathogenetic features (2016) (13)
- Sporadic Creutzfeldt-Jakob disease with MM1-type prion protein and plaques (2004) (13)
- Apolipoprotein E and J immunoreactivity in Gerstmann-Sträussler-Scheinker disease (1994) (13)
- Novel PSEN1 mutations (H214N and R220P) associated with familial Alzheimer's disease identified by targeted exome sequencing (2016) (13)
- ONLY MUTANT PRP PARTICIPATES IN AMYLOID FORMATION IN GERSTMANN-STRÄUSSLER-SCHEINKER DISEASE WITH ALA>VAL SUBSTITUTION AT CODON 117: 21 (1995) (12)
- A progranulin mutation associated with cortico-basal syndrome in an Italian family expressing different phenotypes of fronto-temporal lobar degeneration (2012) (12)
- Mathematical models for the diffusion magnetic resonance signal abnormality in patients with prion diseases (2014) (12)
- Orthochromatic leukodystrophy with pigmented glial cells. AN ADULT CASE WITH CLINICAL‐ANATOMICAL STUDY (1979) (12)
- Clinical and neuropathological phenotype associated with the novel V189I mutation in the prion protein gene (2019) (12)
- Regression of chronic posterior leukoencephalopathy after stop of methotrexate treatment (2009) (12)
- A novel insertional mutation in the prion protein gene: clinical and bio-molecular findings (2008) (12)
- Prions Strongly Reduce NMDA Receptor S-Nitrosylation Levels at Pre-symptomatic and Terminal Stages of Prion Diseases (2019) (11)
- Stratifying the Presymptomatic Phase of Genetic Frontotemporal Dementia by Serum NfL and pNfH: A Longitudinal Multicentre Study (2021) (11)
- MRI abnormalities found 1 year prior to symptom onset in a case of Creutzfeldt–Jakob disease (2016) (11)
- Dreaming of a New World Where Alzheimer’s Is a Treatable Disorder (2019) (11)
- Prion protein hereditary amyloidosis: parenchymal and vascular (1996) (11)
- Variability of the clinical phenotype in an Italian family with dementia associated with an intronic deletion in the GRN gene. (2011) (11)
- Characterizing the Clinical Features and Atrophy Patterns of MAPT-Related Frontotemporal Dementia With Disease Progression Modeling (2021) (11)
- S3-01-03: Prion therapy: Tetracyclic compounds in animal models and patients with Creutzfeldt-Jakob disease (2008) (11)
- Prion Diseases: Time for a Therapy ? (2003) (11)
- The behavioural features of fatal familial insomnia: A new Italian case with pathological verification. (2009) (11)
- Familial frontotemporal dementia associated with the novel MAPT mutation T427M (2005) (11)
- Tau Mutations as a Novel Risk Factor for Cancer-Response. (2018) (11)
- ADULT METACHROMATIC LEUCODYSTROPHY: CLINICOPATHOLOGICAL REPORT OF TWO FAMILIAL CASES WITH SLOW COURSE (1979) (10)
- Cognitive Deficits in Familial Alzheimer’s Disease Associated with M239V Mutation of Presenilin 2 (2006) (10)
- Failure to replicate an association of rs5984894 SNP in the PCDH11X gene in a collection of 1,222 Alzheimer's disease affected patients. (2010) (10)
- A mutation in the 5'-UTR of GRN gene associated with frontotemporal lobar degeneration: phenotypic variability and possible pathogenetic mechanisms. (2014) (10)
- Humoral and T-cell immune response after three doses of mRNA SARS-CoV-2 vaccines in fragile patients: the Italian VAX4FRAIL study (2022) (10)
- Progressive supranuclear palsy with hypertrophy of the olives. An immunocytochemical study of the cytoskeleton of argyrophilic neurons. (1988) (10)
- The A2V mutation as a new tool for hindering Aβ aggregation: A neutron and x-ray diffraction study (2017) (10)
- Missense mutation in GRN gene affecting RNA splicing and plasma progranulin level in a family affected by frontotemporal lobar degeneration (2017) (10)
- Mirror Image of the Amyloid-β Species in Cerebrospinal Fluid and Cerebral Amyloid in Alzheimer's Disease. (2015) (9)
- Site investigation and modelling at "La Maina" landslide (Carnian Alps, Italy) (2006) (9)
- On the variability of the human flocculus and paraflocculus accessorius. (1984) (9)
- Hereditary and sporadic beta-amyloidoses. (2013) (9)
- Abnormal pain perception is associated with thalamo-cortico-striatal atrophy in C9orf72 expansion carriers in the GENFI cohort (2020) (9)
- Ubiquitinated neurites are associated with preamyloid and cerebral amyloid β deposits in patients with hereditary cerebral hemorrhage with amyloidosis Dutch type (2004) (9)
- A novel phenotype of sporadic Creutzfeldt–Jakob disease (2009) (9)
- V363I and V363A mutated tau affect aggregation and neuronal dysfunction differently in C. elegans (2018) (9)
- Panencephalopathic Creutzfeldt‐Jakob Disease with Distinct Pattern of Prion Protein Deposition in a Patient with D178N Mutation and Homozygosity for Valine at Codon 129 of the Prion Protein Gene (2014) (9)
- Gene Expression Imputation Across Multiple Tissue Types Provides Insight Into the Genetic Architecture of Frontotemporal Dementia and Its Clinical Subtypes (2021) (8)
- Cerebral extracellular preamyloid deposits in Alzheimer's disease, Down syndrome and nondemented elderly individuals. (1989) (8)
- A cluster of progranulin C157KfsX97 mutations in Southern Italy: clinical characterization and genetic correlations (2017) (8)
- Impairment of episodic memory in genetic frontotemporal dementia: A GENFI study (2021) (8)
- A novel phenotype of sporadic Creutzfeldt–Jakob disease (2007) (7)
- Megalencephaly with formation of Rosenthal fibers in symmetric subependymal gliomatous proliferations: clinicopathologic report. (1983) (7)
- Disease-related cortical thinning in presymptomatic granulin mutation carriers (2020) (7)
- Skin nerve α-synuclein deposits in a parkinsonian patient with heterozygous parkin mutation. (2019) (7)
- The Revised Self-Monitoring Scale detects early impairment of social cognition in genetic frontotemporal dementia within the GENFI cohort (2021) (7)
- Down syndrome as a key to the time sequence of brain changes in Alzheimer disease. (1992) (7)
- Characterization of Amyloid-β Deposits in Bovine Brains (2016) (7)
- Network structure and transcriptomic vulnerability shape atrophy in frontotemporal dementia (2022) (7)
- Creutzfeldt-Jakob disease: Clinical, EEG and neuropathological findings in a cluster of eleven patients (1983) (7)
- MRI data-driven algorithm for the diagnosis of behavioural variant frontotemporal dementia (2021) (7)
- THE PRION PROTEIN AND CELLULAR CHOLESTEROL HOMEOSTASIS (2002) (7)
- NEUROPATHOLOGICAL CORRELATES OF MAGNETIC RESONANCE ABNORMALITIES IN EXPERIMENTAL PRION DISEASE (1999) (7)
- Italian Frontotemporal Dementia Network (FTD Group-SINDEM): sharing clinical and diagnostic procedures in Frontotemporal Dementia in Italy (2015) (7)
- Creutzfeldt-Jakob disease with a novel extra-repeat insertional mutation in the PRNP gene. (2003) (7)
- A betaPP peptide carboxyl-terminal to Abeta is neurotoxic. (1999) (6)
- Position paper of the Italian Society for the study of Dementias (Sindem) on the proposal of a new Lexicon on Alzheimer disease (2012) (6)
- Medical Informatics Platform (MIP): A Pilot Study Across Clinical Italian Cohorts (2020) (6)
- An atypical case of sporadic fatal insomnia (2009) (6)
- Lower limb areflexia without central and peripheral conduction abnormalities is highly suggestive of Gerstmann–Sträussler–Scheinker disease Pro102Leu (2011) (6)
- PRION PROTEIN ISOFORMS IN THE NEW VARIANT OF GERSTMAN-STRÄUSSLER-SCHEINKER DISEASE Q212P (1998) (6)
- Uncovering the heterogeneity and temporal complexity of neurodegenerative diseases with Subtype and Stage Inference (2018) (6)
- "Thalamic" dementia in herpes encephalitis: clinico-pathological report. (1981) (6)
- Microglial Heterogeneity and Its Potential Role in Driving Phenotypic Diversity of Alzheimer’s Disease (2021) (6)
- Erratum: C9ORF72 Hexanucleotide Repeat Number in Frontotemporal Lobar Degeneration: A Genotype-Phenotype Correlation Study (Journal of Alzheimer's Disease 38, 4, 2014, (799-808)) DOI 10.3233/JAD-131028 (2015) (6)
- Humoral and T-Cell Immune Response After 3 Doses of Messenger RNA Severe Acute Respiratory Syndrome Coronavirus 2 Vaccines in Fragile Patients: The Italian VAX4FRAIL Study (2022) (6)
- Translational Research in Alzheimer’s and Prion Diseases (2017) (6)
- Humoral and T-Cell Immune Response After 3 Doses of Messenger RNA Severe Acute Respiratory Syndrome Coronavirus 2 Vaccines in Fragile Patients: The Italian VAX4FRAIL Study (2022) (6)
- Serpin Signatures in Prion and Alzheimer’s Diseases (2022) (6)
- Evaluation of seismic effects on the landslide deposits of Monte Salta (Eastern Italian Alps) using distinct element method (2007) (6)
- Comparison of clinical rating scales in genetic frontotemporal dementia within the GENFI cohort (2021) (5)
- Synthetic Prion Selection and Adaptation (2018) (5)
- Automatic multispectral MRI segmentation of human hippocampal subfields: an evaluation of multicentric test–retest reproducibility (2020) (5)
- FVEPs in Creutzfeldt–Jacob disease: waveforms and interaction with the periodic EEG pattern assessed by single sweep analysis (2005) (5)
- Quantitative MRI Harmonization to Maximize Clinical Impact: The RIN–Neuroimaging Network (2022) (5)
- Diffuse senile plaques: amorphous or fibrous? (1995) (5)
- Polyanion induced fibril growth enables the development of a reproducible assay in solution for the screening of fibril interfering compounds, and the investigation of the prion nucleation site (2007) (5)
- Effects of Multiple Genetic Loci on Age at Onset in Frontotemporal Dementia. (2016) (4)
- Machine Learning Driven Profiling of Cerebrospinal Fluid Core Biomarkers in Alzheimer’s Disease and Other Neurological Disorders (2021) (4)
- C9orf72, age at onset, and ancestry help discriminate behavioral from language variants in FTLD cohorts (2020) (4)
- Prion Efficiently Replicates in α-Synuclein Knockout Mice (2019) (4)
- Global network structure and local transcriptomic vulnerability shape atrophy in sporadic and genetic behavioral variant frontotemporal dementia (2021) (4)
- Geomorphology and slope instability in the Dolomites (Northern Italy): from Lateglacial to recent geomorphological evidence and engineering geological applications. (2004) (4)
- 22. Multicentric test-retest reproducibility of human hippocampal volumes with FreeSurfer 6.0: A comparison between standard and longitudinal hippocampal subfields segmentation streams applied to 3D T1, 3D FLAIR and high-resolution 2D T2 neuroimaging (2018) (4)
- Iatrogenic Creutzfeldt-Jakob disease with Amyloid-β pathology: an international study (2018) (4)
- Clinical trials. (2018) (4)
- Differential impairment of cerebrospinal fluid synaptic biomarkers in the genetic forms of frontotemporal dementia (2022) (4)
- Progressive supranuclear palsy with hypertrophy of the olives (2004) (4)
- Divergent cognitive status with the same Braak stage of neurofibrillary pathology: does the pattern of amyloid-β deposits make the difference? (2014) (4)
- C9ORF72 hexanucleotide repeat number in frontotemporal lobar degeneration: a genotype-phenotype correlation study. (2015) (4)
- DISTINCTIVE PrP ISOFOMS IN GERSTMANN-STRÄUSSLER-SCHEINKER DISEASE WITH TANGLES (1998) (4)
- In Situ Tissue Labeling of Cerebral Amyloid Using HIV-Related Tat Peptide (2018) (4)
- Comment on: Neurotoxicity of prion peptide 106–126 not confirmed, by Beat Kunz, Erika Sandmeier, Philipp Christen (2000) (4)
- An Automated Toolbox to Predict Single Subject Atrophy in Presymptomatic Granulin Mutation Carriers. (2022) (3)
- Evaluation Of Landslide Hazard AndRisk In North-eastern Italy (2004) (3)
- Sneddon's syndrome and renal carcinoma. Case report. (1992) (3)
- A novel bio-inspired strategy to prevent amyloidogenesis and synaptic damage in Alzheimer’s disease (2022) (3)
- Data‐driven staging of genetic frontotemporal dementia using multi‐modal MRI (2022) (3)
- Cytotoxicity of PrP Peptides (2004) (3)
- Effects of peptidyl-prolyl isomerase 1 depletion in animal models of prion diseases (2018) (3)
- Dissemination in time and space in presymptomatic granulin mutation carriers: a GENFI spatial chronnectome study (2021) (3)
- SYMPTOM ONSET IN GENETIC FRONTOTEMPORAL DEMENTIA (2017) (3)
- A PRION PROTEIN FRAGMENT MODIFIES PLASMA MEMBRANE VISCOSITY AND INTRACELLULAR. CALCIUM LEVEL: 151 (1995) (3)
- P301L tau mutation leads to alterations of cell cycle, DNA damage response and apoptosis: evidence for a role of tau in cancer. (2022) (3)
- Progressive supranuclear palsy in the course of subclavian steal syndrome. (1981) (3)
- Mendelian randomization implies no direct causal association between leukocyte telomere length and amyotrophic lateral sclerosis (2020) (3)
- The Contribution of the Amyloid Hypothesis to the Understanding of Alzheimer's Disease: A Critical Overview (2012) (3)
- Elevated CSF and plasma complement proteins in genetic frontotemporal dementia: results from the GENFI study (2022) (3)
- Contributions of Molecular and Optical Techniques to the Clinical Diagnosis of Alzheimer’s Disease (2020) (2)
- Microglia and complement in the cortex of Creutzfeldt-Jakob disease and comparison with Alzheimer’s disease (2000) (2)
- Measles Inclusion‐Body Encephalitis: Neuronal Phosphorylated Tau Protein is Present in the Biopsy but not in the Autoptic Specimens of the Same Patient (2016) (2)
- [Intracranial and spinal dermo-epidermoid tumours. Anatomoclinical study (author's transl)]. (1978) (2)
- Cerebrospinal fluid levels of amyloid β‐protein precursor are low in Gerstmann‐Sträussler‐Scheinker disease, Indiana kindred (1994) (2)
- A case of progressive frontal lobe syndrome in a sporadic form of Cerebral Amyloid Angiopathy: A singular overlap with fronto-temporal dementia? (2015) (2)
- GENFI - The GENetic Frontotemporal dementia Initiative (2012) (2)
- Prion disease: A promising rating scale for prion disease clinical research (2013) (2)
- Meningiomas. A light and electron microscopy study. (1981) (2)
- PMCA-Based Detection of Prions in the Olfactory Mucosa of Patients With Sporadic Creutzfeldt–Jakob Disease (2022) (2)
- Multi-centre and multi-vendor reproducibility of a standardized protocol for quantitative susceptibility Mapping of the human brain at 3T. (2022) (2)
- Brain Metabolism and Amyloid Load in Individuals With Subjective Cognitive Decline or Pre–Mild Cognitive Impairment (2022) (2)
- Sporadic Creutzfeldt-Jakob Disease: The Extent of Microglia Activation Is Dependent on the Biochemical Type of PrP Sc (2005) (2)
- A case of multiple sclerosis with pure, massive superficial demyelination (2012) (2)
- Frequency and Longitudinal Course of Motor Signs in Genetic Frontotemporal Dementia (2022) (2)
- Author Correction: Susceptible genes and disease mechanisms identified in frontotemporal dementia and frontotemporal dementia with Amyotrophic Lateral Sclerosis by DNA-methylation and GWAS (2018) (2)
- Encephalopathy with myoclonus in an uremic non dialysed patient. A case report. (1982) (2)
- [Fabry's disease and familial lymphedema. Description of 2 cases]. (1980) (2)
- Assessing the possible future development of the Tessina landslide using numerical modelling (2009) (1)
- NEUROTOXICITY OP A ??PP PEPTIDE OTHER THAN A??: (1996) (1)
- Anti-amyloidogenic activity of tetracyclines: In vitro studies (2000) (1)
- Early cortical and late striatal diffusion restriction on 3T MRI in a long‐lived sporadic creutzfeldt–jakob disease case (2019) (1)
- From brain volumes to subgroup classification in genetic mutation carriers for frontotemporal dementia: A cluster analysis in the GENFI study (2021) (1)
- ANTI-Aβ AUTOANTIBODIES IN CAA AND AD: DIFFERENT SINGERS FOR THE SAME ARIA? (2014) (1)
- Preventive pharmacological treatment in subjects at risk for fatal familial insomnia: science and public engagement (2022) (1)
- Italian adaptation of the Uniform Data Set Neuropsychological Test Battery (I-UDSNB 1.0): development and normative data (2022) (1)
- A “presymptomatic” case of Gerstmann-Sträussler-Scheinker disease from the indiana kindred has cerebellar deposits of prion protein amyloid and a mutation in the prion protein gene (1992) (1)
- Structural brain splitting is a hallmark of Granulin-related frontotemporal dementia (2022) (1)
- Brainstem Sparing in Human Prion Disease: Sleep and Autonomic Function in a Long Survival Case Report (2016) (1)
- MULTIPLE DISTINCT ATROPHY PATTERNS FOUND IN GENETIC FRONTOTEMPORAL DEMENTIA USING SUBTYPE AND STAGE INFERENCE (SUSTAIN) (2017) (1)
- 165 Prior protein (PrP) residue 129 Val in Gerstmann-Sträussler-Scheinker (GSS) disease with mutation PRNP P102L (1996) (1)
- Immune-related genetic enrichment in frontotemporal dementia (2017) (1)
- STRUCTURAL VARIATIONS OF ABNORMAL PRION PROTEIN IN GERSTMANN-STRÄUSSLER-SCHEINKER DISEASE (2002) (1)
- Abandoned children and population genetics: the cases of Iggio and Tiola (2012) (1)
- MRI data quality assessment for the RIN - Neuroimaging Network using the ACR phantoms. (2022) (1)
- Therapeutic Approaches to Prion Diseases : In Vitro Studies with Tetracycline Compounds (2002) (1)
- Impairment of episodic memory in genetic frontotemporal dementia: A GENFI study. (2021) (1)
- Data-driven algorithm for the diagnosis of behavioral variant frontotemporal dementia (2019) (1)
- Anti-amyloidogenic effect of tetracyclines in Prion and Alzheimer disease models (2002) (1)
- Spatiotemporal analysis for detection of pre-symptomatic shape changes in neurodegenerative diseases: applied to GENFI study (2018) (1)
- A 52‐Year‐Old Man with Myoclonic Jerks (2016) (1)
- Protein Aggregates in Neurodegenerative Disorders (2008) (1)
- Examining empathy deficits across familial forms of frontotemporal dementia within the GENFI cohort (2022) (1)
- Characterization of Beta Amyloid Deposition in Cattle Brain (2012) (1)
- ASTROCYTOSIS AND SPONGIFORM CHANGES OF THE WHITE MATTER IN CREUTZFELDT‐JAKOB DISEASE (CJ): 167 (1987) (1)
- P3-332 Familial frontotemporal dementia associated with the novel tau mutation T427M (2004) (1)
- EXPERIMENTAL (HAMSTER) SCRAPIE: ANTIGENIC PROFILE OF CEREBRAL PrP DEPOSITS (1993) (1)
- Alzheimer's disease (AD) : AT8 recognizes degenerating ectopic neurons and astrocytes in the subcortical white matter. (2005) (1)
- ALZHEIMERʼS DISEASE AND HEREDITARY (DUTCH-TYPE) CEREBRAL HEMORRHAGE: COEXISTENCE OF AMYLOID PRECURSOR PROTEIN AND AMYLOID PROTEIN IN CEREBRAL VESSEL WALLS (1990) (1)
- P3-382 Insertional mutation in the prion protein gene presenting with Schizophrenia (2004) (1)
- Psychological Impact of Predictive Genetic Testing for Inherited Alzheimer Disease and Frontotemporal Dementia (2022) (1)
- MULTIPLE DISTINCT ATROPHY PATTERNS FOUND IN GENETIC FRONTOTEMPORAL DEMENTIA USING SUBTYPE AND STAGE INFERENCE (SUSTAIN) (2017) (1)
- PROGRESSIVE SUPRANUCLEAR PALSY (PSP): OLIVARY NEURONS AFTER DEAFFERENTATION CONTAIN PHOSPHORILATED NEUROFILAMENTS (P-NF), TANGLES DO NOT (1987) (1)
- Subtype and stage inference identifies distinct atrophy patterns in genetic frontotemporal dementia that MAP onto specific MAPT mutations (2020) (1)
- Practice effects in genetic frontotemporal dementia and at-risk individuals: a GENFI study (2021) (1)
- Mathematical models of diffusion in prion disease (2012) (1)
- Anthracyclines and Amyloidosis (1998) (1)
- CSF biomarkers for Amyloid Related Imaging Abnormalities (ARIA) in immunotherapy trials of Alzheimer’s disease and Cerebral Amyloid Angiopathy: report from the iCAß International Network (2015) (1)
- 430 Short and long-latency evoked responses in Creutzfeld-Jacob Disease (CJD) (1998) (0)
- Accuracy of biomarkers in predicting conversion to dementia in MCI subjects: The statistical analysis plan of the interceptor study (2021) (0)
- Efficient RT-QuIC seeding activity for α-synuclein in olfactory mucosa samples of patients with Parkinson’s disease and multiple system atrophy (2019) (0)
- Distinct patterns of brain atrophy in genetic frontotemporal dementia: visual rating scales in the GENFI cohort (2016) (0)
- Recommendations for addressing the translational gap between experimental and clinical research on amyloid diseases (2022) (0)
- Biochemical and biophysical features of disease-associated tau mutants V363A and V363I (2022) (0)
- Recommendations for addressing the translational gap between experimental and clinical research on amyloid diseases (2022) (0)
- Tau mutations lead to chromosome aberrations: A new role of tau in the pathogenesis of genetic tauopathies? (2010) (0)
- BRAIN DEPOSITION OF PYROGLUTAMATE Aβ IN Aβ AMYLOIDOSIS (2014) (0)
- EARLY REGIONAL HYPOMETABOLISM IN PRE-SYMPTOMATIC CARRIERS OF MAPT: A GENFI SUB-STUDY (2019) (0)
- Distribution of beta-amyloid peptides in leptomeningeal amyloid deposits and cerebrospinal fluid in patients with Alzheimer's disease: A mirror image (2012) (0)
- vCJD: a single non adaptive strain (2011) (0)
- Grey matter differences in genetic frontotemporal dementia: Results from the genfi study (2015) (0)
- S1-03-03 A new BSE prion strain (2006) (0)
- Defining strain characteristics for variant CJD cases from five different countries (2011) (0)
- A prion protein fragment increases intracellular calcium and activates superoxide production and cell migration of human neutrophils through a receptor-mediated mechanism (1995) (0)
- Synthetic Prion Selection and Adaptation (2018) (0)
- Good Protein, Bad Protein: A New Aβ Variant Can Be Both (2009) (0)
- Determination of the amino-terminal cleavage site of PRPRES in GSS F198S (2000) (0)
- Anti-Aß autoantibodies and endothelial damage during spontaneous Amyloid-Related Imaging Abnormalities (ARIA): report from the inflammatory cerebral amyloid angiopathy and alzheimer's disease biomarkers collaborative network (iCAB) (2013) (0)
- Plasma Neuro fi lament Light for Prediction of Disease Progression in Familial Frontotemporal Lobar Degeneration (0)
- 9 Let's treat Alzheimer's disease - genetic aspects (2012) (0)
- Coated Nanogolds as Novel Potent Anti-prion Compounds (2010) (0)
- WHITE MATTER HYPERINTENSITIES IN GENETIC FRONTOTEMPORAL DEMENTIA: A GENFI STUDY (2017) (0)
- The inner fl uctuations of the brain in presymptomatic Frontotemporal Dementia : The chronnectome fi ngerprint (2019) (0)
- A data‐driven disease progression model of fluid biomarkers in genetic FTD (2021) (0)
- Correction: Italian adaptation of the Uniform Data Set Neuropsychological Test Battery (I‑UDSNB 1.0): development and normative data (2023) (0)
- Neuropathological and ultrastructural alterations in transgenic mice expressing the fatal familial insomnia mutation (2014) (0)
- Short Communication Chronic wasting disease and atypical forms of bovine spongiform encephalopathy and scrapie are not transmissible to mice expressing wild-type levels of human prion protein (2012) (0)
- PROGRESSIVE SUPRANUCLEAR PALSY (PSP): OLIVARY NEURONS AFTER DEAFFERENTATION CONTAIN PHOSPHORILATED NEUROFILAMENTS (P‐NF), TANGLES DO NOT 166 (1987) (0)
- Table of Contents (1991) (0)
- 300 Hemizygous prion protein gene (prnp) knockout in cattle fibroblasts (2008) (0)
- S1-03-06: Treatment of transmissible spongiform encephalopathies with doxycycline (2006) (0)
- Correction to: A nonsynonymous mutation in PLCG2 reduces the risk of Alzheimer’s disease, dementia with Lewy bodies and frontotemporal dementia, and increases the likelihood of longevity (2020) (0)
- How long and how frequent follow-up care should be for lower-grade gliomas? Retrospective study on patients with LGGs at Neurological Institute Besta of Milan (2021) (0)
- PROTEINASE K (PK) RESISTANT PRION PROTEIN (PRP) ISOFORMS IN GERSTMANN-STRÄUSSLER-SCHEINKER DISEASE (GSS) F198S (1996) (0)
- Distinct patterns of brain atrophy in Genetic Frontotemporal Dementia Initiative (GENFI) cohort revealed by visual rating scales (2018) (0)
- Measles Inclusion‐Body Encephalitis: Neuronal Phosphorylated Tau Protein is Present in the Biopsy but not in the Autoptic Specimens of the Same Patient (2016) (0)
- Neurological Sciences: a roadmap for the future (2021) (0)
- Idiopathic progressive chorea: misnomer or still reality? A case with neuropathological disconfirmation (2014) (0)
- Asymmetry of Permutation Entropy in Early Creutzfeldt-Jakob Disease: A Clue to a Specific Pathological Process? (2015) (0)
- ITALIAN NETWORK FOR AUTOSOMAL DOMINANT ALZHEIMER'S DISEASE AND FRONTOTEMPORAL LOBAR DEGENERATION (ITALIANDIAFN) (2014) (0)
- ITALIAN NETWORK FOR AUTOSOMAL DOMINANT ALZHEIMER'S DISEASE AND FRONTOTEMPORAL LOBAR DEGENERATION (ITALIANDIAFN) (2014) (0)
- [Temporal necrotizing encephalitis with a subacute course; a clinical and anatomical case]. (1979) (0)
- P3-200 Relationship between neurofibrillary pathology and Aβ deposition in Alzheimer disease (2006) (0)
- ALZHEIMERʼS DISEASE (AD): ABSENCE OF SIDE-TO-SIDE AND PATIENT-TO-PATIENT DIFFERENCES IN THE INTRACORTICAL DISTRIBUTION OF SENILE PLAQUES (SP) IN THE ANGULAR GYRUS (1986) (0)
- Topographic distribution of PRPRES in Creutzfeldt-Jakob disease as revealed by immunohistochemistry (2000) (0)
- Short Communication f3PP and Tau Interaction A Possible Link between Amyloid and Neurofibrillary Tangles in Alzheimer's Disease (2007) (0)
- Tauopathy in human and experimental variant Creutzfeldt‐Jakob disease (2007) (0)
- Prion Efficiently Replicates in α-Synuclein Knockout Mice (2019) (0)
- sporadic CJD VV 2 ( ataxic type ) Towards an early clinical diagnosis of (2017) (0)
- PRION PROTEIN IMMUNOHISTOCHEMISTRY IN CREUTZFELDT-JAKOB DISEASE (1998) (0)
- Prion protein fragment 106–126-induces astroglial proliferation through the activation of l-type calcium channels (1995) (0)
- Insertional mutation in prion protein gene presenting with schizophrenic-like symptoms (2004) (0)
- A panel of CSF proteins separates genetic frontotemporal dementia from presymptomatic mutation carriers: a GENFI study (2021) (0)
- Brain metabolism, amyloid load and neuropsychological correlates in preclinical dementia stages (2021) (0)
- AnAntibody Raised Against a Conserved Sequence ofthePrion Protein Recognizes Pathological Isoforms inHumanandAnimal Prion Diseases, Including Creutzfeldt-Jako (1998) (0)
- Corrigendum: PMCA-based detection of prions in the olfactory mucosa of patients with sporadic Creutzfeldt–Jakob disease (2023) (0)
- Oral Sessions (2019) (0)
- Haem oxygenase-1 mRNA induction by a prion protein fragment in rat astroglial cells (1995) (0)
- An In Vivo 11C-(R)-PK11195 PET and In Vitro Pathology Study of Microglia Activation in Creutzfeldt-Jakob Disease (2017) (0)
- P3-238: A novel missense mutation in PSEN2 gene associated with a clinical phenotype of frontotemporal dementia (2008) (0)
- The Free Cued Selective Reminding Test detects episodic memory impairment in the presymptomatic period of familial frontotemporal dementia within the GENFI cohort (2020) (0)
- CEREBRAL PREAMYLOID DEPOSITS AND CONGOPHILIC ANGIOPATHY IN AGED DOGS: 212 (1990) (0)
- IN GENETIC FRONTOTEMPORAL DEMENTIA, FUNCTIONAL NETWORK EFFICIENCY IS MAINTAINED UNTIL THE ONSET OF SYMPTOMS: EVIDENCE FOR FUNCTIONAL RESILIENCE TO STRUCTURAL CHANGE (2017) (0)
- P4-415 ST1859 reduces prion infectivity and increase survival in experimental scrapie (2004) (0)
- Neo-antigenic expression in rheumatoid synovia? (1980) (0)
- Spontaneous spongiform encephalopathy in a young adult rhesus monkey. (1996) (0)
- Pattern of progression in MAPT‐related frontotemporal dementia: Results from the GENFI study (2021) (0)
- Electroretinogram (ERGs) and visual evoked potentials (VEPs) study in prion disease (CJD) (2019) (0)
- Molecular subtypes of Alzheimer’s disease (2018) (0)
- Slope instability around the Sauris reservoir (North-eastern Italy) (2004) (0)
- Mutations in MAPT give rise to aneuploidy in animal models of tauopathy (2013) (0)
- Gene expression profiling of cjd brains: Validation of a novel disease signature for neurodegeneration in primates (2015) (0)
- Defined α-synuclein prion-like molecular assemblies spreading in cell culture (2014) (0)
- LONGITUDINAL ASSOCIATION BETWEEN APATHY AND COGNITIVE DECLINE IN PRE- AND POST-SYMPTOMATIC GENETIC FRONTOTEMPORAL DEMENTIA (2019) (0)
- Elevated CSF and plasma complement proteins in genetic frontotemporal dementia: results from the GENFI study (2022) (0)
- Transmission studies of a mixed MV sporadic Creutzfeldt-Jakob disease in transgenic mice models (2012) (0)
- Hierarchical spectral clustering reveals brain size and shape changes in asymptomatic carriers of C9orf72 (2022) (0)
- The Revised Self-Monitoring Scale detects early impairment of social cognition in genetic frontotemporal dementia within the GENFI cohort (2021) (0)
- Grey matter differences in genetic frontotemporal dementia: Results from the genfi study (2015) (0)
- Quality assessment, variability and reproducibility of anatomical measurements derived from T1-weighted brain imaging: The RIN-Neuroimaging Network case study. (2023) (0)
- Identification of evolutionarily conserved gene networks mediating neurodegenerative dementia (2018) (0)
- Atrophy patterns in sporadic and genetic behavioral variant frontotemporal dementia reflect brain network architecture (2021) (0)
- Tau protein and chromosome stability (2011) (0)
- Multimodal imaging analysis of C9orf72-associated FTD in the Genetic Frontotemporal dementia Initiative (GENFI) study (2016) (0)
- SPATIAL MEMORY PERFORMANCE CLASSIFIES MILD COGNITIVE IMPAIRMENT DUE TO ALZHEIMER'S DISEASE (2014) (0)
- Differential impairment of cerebrospinal fluid synaptic biomarkers in the genetic forms of frontotemporal dementia (2022) (0)
- IN GENETIC FRONTOTEMPORAL DEMENTIA, FUNCTIONAL NETWORK EFFICIENCY IS MAINTAINED UNTIL THE ONSET OF SYMPTOMS: EVIDENCE FOR FUNCTIONAL RESILIENCE TO STRUCTURAL CHANGE (2017) (0)
- Species and disease specific prion protein (PrP) isoforms are detected by antibodies (abs) raised against a highly conserved mid-region sequence (1997) (0)
- Severe microcephaly with polynodular heterotopia: a high‐field MRI and neuropathological case study (2013) (0)
- Italian, European, And International Neuroinformatics Efforts: An Overview. (2022) (0)
- Presymptomatic cerebral perfusion biomarker changes in genetic frontotemporal dementia: results from the GENetic Frontotemporal dementia Initiative (GENFI) (2016) (0)
- ANTHRACYCLINES EFFECTIVE AGAINST EXPERIMENTAL SCRAPIE (1997) (0)
- Cytokine production by glioblastoma and astrocytoma cell lines after stimulation with the human prion peptide 82–146 (1998) (0)
- Educational interventions to improve detection and management of cognitive decline in primary care—An Italian multicenter pragmatic study (2022) (0)
- Cell membrane viscosity is increased by a prion protein fragment (1994) (0)
- Differential synaptic marker involvement in the different genetic forms of frontotemporal dementia (2021) (0)
- Patterns of longitudinal neuroanatomical change in genetic FTD: results from the Genetic FTD Initiative (GENFI) (2016) (0)
- ASYMMETRIC CEREBRAL ATROPHY IN ALZHEIMERʼS DISEASE (1986) (0)
- Short Communication A b PP Peptide Carboxyl-Terminal to A b Is Neurotoxic (1999) (0)
- Clinical and neuropathological phenotype associated with the novel V189I mutation in the prion protein gene (2019) (0)
- Neuropsychiatric symptoms in the genetic frontotemporal dementia initiative (GENFI) cohort (2016) (0)
- ITALIAN CONSENSUS RECOMMENDATIONS FOR THE ETIOLOGICAL DIAGNOSIS IN MEMORY CLINICS (2019) (0)
- Brain Dysfunction Associated with Amyloid Fibrils and Other Aggregated Proteins (2008) (0)
- The A2V mutation as a new tool for hindering Aβ aggregation: A neutron and x-ray diffraction study (2017) (0)
- Atypical tauopathywith massive involvement of the white matter (Neuropathology and Applied Neurobiology (2008) 34, (468-472)) (2009) (0)
- Clinical phenotypic variability in an Italian family bearing the IVS6+5_8delGTGA mutation in PGRN gene (2011) (0)
- CEREBRAL PERFUSION AS AN IMAGING BIOMARKER OF PRESYMPTOMATIC GENETIC FRONTOTEMPORAL DEMENTIA: PRELIMINARY RESULTS FROM THE GENETIC FRONTOTEMPORAL DEMENTIA INITIATIVE (GENFI) (2016) (0)
- TOPOGRAPHY OF AT8 IMMUNOREACTIVITY IN GERSTMANN-STRÄUSSLER-SCHEINKER DISEASE, INDIANA KINDRED (1997) (0)
- 161 PrP peptides and pathogenesis of prion diseases (1996) (0)
- Fas-L expression in sporadic Creutzfeldt-Jakob disease: an immunohistochemistry study (2009) (0)
- Detecting clinical progression from abnormal regional brain volumes at baseline in genetic frontotemporal dementia: A GENFI study (2021) (0)
- The prion protein fragment 106-126 stimulates inducible nitric oxide synthase in human microglia via the activation of p38 mitogen-activated protein kinase (2001) (0)
- Clinical features, pathophysiology and management of fatal familial insomnia (2017) (0)
- Author Correction: Common variants in Alzheimer’s disease and risk stratification by polygenic risk scores (2023) (0)
- Tauopathy in human and experimental variant Creutzfeldt-Jakob disease: 48.6 (2007) (0)
- A neurotoxic prion protein fragment induces hypertrophy and proliferation of rat astroglial cells in vitro. (1994) (0)
- O2-01-08 Tauopathy in variant Creutzfeldt-Jakob disease (2006) (0)
- Prion and Prion-like Diseases in Humans (2013) (0)
- PREAMYLOID DEPOSITS PRECEDE SENILE PLAQUE FORMATION IN THE DEVELOPMENT OF ALZHEIMER CHANGES IN DOWN SYNDROME (1988) (0)
- OP-BRAI180237 2895..2907 (2018) (0)
- Phenotypic heterogeneity of Alzheimer's disease: Toward the identification of molecular determinants underlying distinct clinicopathological subgroups (2012) (0)
- FRONTO-SUBCORTICAL HYPOPERFUSION IN PRESYMPTOMATIC FTD IS ASSOCIATED WITH BEHAVIORAL MEASURES, BUT NOT COGNITIVE DEFICITS: THE GENFI STUDY (2017) (0)
- Automatic multispectral MRI segmentation of human hippocampal subfields: an evaluation of multicentric test–retest reproducibility (2020) (0)
- A soluble form of prion protein in human cerebrospinal fluid as a potential source of PRP amyloid (1992) (0)
- Robust MR-free Grey Matter Extraction in Amyloid PET/CT Studies with Deep Learning (2020) (0)
- TITLE PAGE Title: Faster Cortical Thinning and Surface Area Loss in Presymptomatic and Symptomatic C9orf72 Repeat Expansion Adult Carriers Running head: Cortical thinning in C9orf72 expansion carriers (2020) (0)
- PROCESS FOR DETECTING PRP USING AN ANTIBOTC FROM THE FAMILY OF AMINOGLYCOSDES ( 75 ) Inventors (2017) (0)
- TOPOGRAPHY OF PHOSPHORYLATED TAU IMMUNOREACTIVITY IN ALZHEIMER DISEASE, PROGRESSIVE SUPRANUCLEAR PALSY AND PICK DISEASE (1996) (0)
- Prions Strongly Reduce NMDA Receptor S-Nitrosylation Levels at Pre-symptomatic and Terminal Stages of Prion Diseases (2019) (0)
- Autologous anti-Aß antibodies in CAA-ri: New biomarker for detection of amyloid-related imaging abnormalities (ARIA) during Aß-disease modifying therapies for AD (2013) (0)
- Sporadic creutzfeldt-Jakob disease coexistence of biochemically distinct types of PRPSC in the same brain (2000) (0)
- Clinic and physiopathologic update on prion's encephalopathy (2007) (0)
- Targeting ß-amyloid by the A2V Aß variant: a novel disease-modifying strategy for the treatment of Alzheimer’s disease (2014) (0)
- Temporal dynamics predict symptom onset and cognitive decline in familial frontotemporal dementia. (2022) (0)
- Trajectory of apathy, cognition and neural correlates in the decades before symptoms in frontotemporal dementia (2020) (0)
- Creutzfeldt-Jakob disease with one extra-repeat insertion in PRNP (2001) (0)
- Erratum to: APP mutations in the Aβ coding region are associated with abundant cerebral deposition of Aβ38 (2013) (0)
- PRESYMPTOMATIC WHITE MATTER INTEGRITY LOSS IN FAMILIAL FRONTOTEMPORAL DEMENTIA IN THE GENETIC FRONTOTEMPORAL DEMENTIA INITIATIVE (GENFI) COHORT: A MULTI-CENTRE, CROSS-SECTIONAL, DIFFUSION TENSOR IMAGING STUDY (2017) (0)
- Preserving the brain: forum on neurodegenerative diseases. (2023) (0)
- Gene Expression Profiling of Prion‐Infected Brains: a Novel Disease Signature for Neurodegeneration in Humans (2016) (0)
- LONGITUDINAL ASSOCIATION BETWEEN APATHYAND COGNITIVE DECLINE IN PRE- AND POST-SYMPTOMATIC GENETIC FRONTOTEMPORAL DEMENTIA STRUCTURAL MRI TELL ABOUT A/T/N STAGING? (2019) (0)
- Corrigendum : Cerebral perfusion changes in presymptomaticgenetic frontotemporal dementia: a GENFIstudy (Brain (2019) DOI: 10.1093/brain/awz039) (2019) (0)
- 162 Alzheimer's and prion diseases: Soluble proteins are altered in the brain. Why? (1996) (0)
- Clinical neuropathology of Creutzfeldt-Jakob disease. (1997) (0)
- Structural MRI predicts clinical progression in presymptomatic genetic frontotemporal dementia: findings from the GENetic Frontotemporal dementia Initiative cohort (2023) (0)
- Pathogenetic role of anti-AB autoantibodies in Cerebral Amyloid Angiopathy-related inflammation and Alzheimer's disease (2012) (0)
- Altered Brain Hemoglobin Gene Expression in the Frontal Cortex of Patients with Alzheimer's and Acquired Creutzfeldt‐Jakob's Disease (2017) (0)
- Clinical, Pathological, and Molecular Characterization of Gerstmann-Sträussler-Scheinker Disease in the Indiana Kindred ( PRNP F198S) (1998) (0)
- A new APP mutation prevents synaptic degeneration in Alzheimer Disease model (2014) (0)
- CHARACTERISTICS AND DISTRIBUTION OF PrP IN THE NEW VARIANT OF CREUTZFELDT-JAKOB DISEASE (1997) (0)
- Neurodegenerative effects induced by β-amyloid and PRP peptides: Similarities and differences (1994) (0)
- Corrigendum to “Dissemination in time and space in presymptomatic granulin mutation carriers: A spatial chronnectome study” [Neurobiology of Aging Volume 108, December 2021, Pages 155–167] (2022) (0)
- α-Synuclein Amyloids Hijack Prion Protein to Gain Cell Entry, Facilitate Cell-to-Cell Spreading and Block Prion Replication (2017) (0)
- PMCA-replicated PrPD in urine of vCJD patients maintains infectivity and strain characteristics of brain PrPD: Transmission study (2019) (0)
- S1-03-05 CELLULAR PRION PROTEIN AS THERAPEUTIC TARGET (2006) (0)
- A common strain of agent is present in variant CJD cases from five different countries (2010) (0)
- Fabrys disease neuro pathological and biochemical study (1981) (0)
This paper list is powered by the following services:
What Schools Are Affiliated With Fabrizio Tagliavini?
Fabrizio Tagliavini is affiliated with the following schools:
